作为慢性氧化性疾病的治疗点的逆氧化恒温:对癌症治疗的影响
Moon Nyeo Park1, Min Choi1, Rony Abdi Syahputra2
1College of Korean Medicine, Kyung Hee University, 1-5 Hoegidong, Dongdaemun-gu, Seoul 02447, Republic of Korea.
Antioxidants (Basel, Switzerland)
|February 27, 2026
概括
反应性氧物种 (ROS) 现在被理解为重要的信号分子,而不仅仅是破坏性剂. 慢性疾病源于被破坏的氧化还原平衡,需要针对性治疗,而不是广泛的抗氧化方法.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 活性氧物种 (ROS) 传统上与氧化应激和组织损伤有关.
- 新兴证据强调ROS作为细胞适应和生存中的关键信号分子.
- 慢性疾病涉及复杂的氧化还原生物学,不仅仅是简单的氧化损伤.
研究的目的:
- 重新评估氧化还原失衡在慢性疾病发病过程中的作用.
- 区分氧化应激和氧化还原信号.
- 提出一种新的框架来理解慢性疾病是氧化还原平衡的障碍.
主要方法:
- 关于ROS和慢性疾病的当前文献的综述.
- 对氧化还原敏感的转录节点 (KEAP1-NRF2,FOXO,HIFs,NF-κB) 的分析.
- 使用癌症作为氧化还原成和信号传递的模型的案例研究.
主要成果:
- 慢性疾病的结果是不适应的氧化还原平衡,而不仅仅是氧化损伤.
- 癌症中ROS水平升高支持瘤原体信号传递和治疗耐药性.
- 由于ROS的双重作用,非特定的抗氧化剂策略是无效的.
结论:
- 有效的疾病干预需要上下文依赖的氧化还原调制.
- 治疗性氧化还原重编程为精密氧化还原医学提供了一种新策略.
- 未来的方向包括生物标志物引导的分层和特定阶段的向.
相关概念视频
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
Redox Reactions
1.2K
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
1.2K
Redox Reactions
59.1K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
59.1K
Peroxisomes
21.7K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
21.7K
Redox Equilibria: Overview
1.7K
A reduction-oxidation reaction is commonly called a redox reaction. In a redox reaction, electrons are transferred from one species to another rather than being shared between or among atoms. The reducing agent or reductant is the species that loses electrons and gets oxidized in the process. The species that gains electrons and gets reduced in the process is the oxidizing agent or oxidant. Redox reactions are represented as two separate equations called half-reactions, where one equation...
1.7K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


